Status:
ENROLLING_BY_INVITATION
Conscious Sedation With Suprainguinal Facia Iliaca Block Versus Ilioinguinal Iliohypogastric Block for TAVI
Lead Sponsor:
Ain Shams University
Conditions:
Aortic Stenosis
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
the aim of the present study is to compare suprainguinal fascia iliaca block and ilioinguinal-iliohypogastric (II-IH) nerve block in improving the quality of conscious sedation, including reducing pat...
Eligibility Criteria
Inclusion
- aged \>20 years with severe aortic stenosis undergoing elective, non-emergent, non-urgent transfemoral Sapien 3TM (Edwards Lifesciences Corp., Irvine, CA, USA) or CoreValveTM (Medtronic, Minneapolis, MN, USA) implantation were included in the study
Exclusion
- younger than 20 years
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06911463
Start Date
March 1 2025
End Date
September 1 2025
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams university
Cairo, Egypt